KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 0.77.

  • Edwards Lifesciences' Equity Ratio rose 376.8% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 376.8%. This contributed to the annual value of 0.77 for FY2024, which is 740.64% up from last year.
  • Per Edwards Lifesciences' latest filing, its Equity Ratio stood at 0.77 for Q3 2025, which was up 376.8% from 0.79 recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Equity Ratio registered a high of 0.79 during Q2 2025, and its lowest value of 0.65 during Q1 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.72 (2023), whereas its average is 0.72.
  • As far as peak fluctuations go, Edwards Lifesciences' Equity Ratio soared by 1210.67% in 2021, and later decreased by 26.73% in 2023.
  • Edwards Lifesciences' Equity Ratio (Quarter) stood at 0.69 in 2021, then grew by 2.02% to 0.7 in 2022, then rose by 2.49% to 0.72 in 2023, then rose by 7.41% to 0.77 in 2024, then decreased by 0.25% to 0.77 in 2025.
  • Its Equity Ratio stands at 0.77 for Q3 2025, versus 0.79 for Q2 2025 and 0.78 for Q1 2025.